The COVID Vaccines and SIRNA Delivery Challenge

It's pretty exciting because we've spoken on this podcast with a number of companies which are using targeted nanoparticles. It seems like this whole idea is really evolving very quickly if we can get RNA in the right place. People are going after a number of different muscular diseases. There are some genetic diseases typically, gain of function sort of genetically dominant diseases where inappropriate gene expression is occurring or too much of a particular gene is being expressed.